BioSpace News Archive

BioCentriq, Inc announced today that they’ve completed a study designed to test transfection of T-cells with GFP mRNA for evaluation of cell viability, transfection efficiency, and post transfection growth using Kytopen’s Flowfect® technology.

Jaguar Health, Inc. today provided updates regarding the Company’s focus on rare and orphan disease indications: short bowel syndrome (SBS), microvillus inclusion disease (MVID), and cholera.

LAPIX Therapeutics, Inc. today announced the successful outcome of its pre-IND meeting request with the U.S. Food and Drug Administration (FDA).

Devonian Health Group Inc. is pleased to announce that Mr. Pierre Montanaro, President and Chief Executive Officer of the Corporation, is scheduled to present at the BIO CEO & Investor Conference taking place at the New York Marriott Marquis on February 6-9, 2023.

Elaborate, the tool that doctors and their staff use to deliver contextualized, action-oriented lab results to patients, announced today it has raised $10 million in Seed funding.

Unilabs, a leading diagnostic services provider, and Ambry Genetics, a leader in clinical diagnostic testing and a subsidiary of REALM IDx, have entered an exclusive partnership to enhance high-quality genetic testing services for government-sponsored and biopharma companies conducting international clinical trials and research.

GE HealthCare and Sound Technologies, the global veterinary imaging leader, announced an agreement to distribute the Vscan Air™, a cutting-edge, wireless pocket-sized ultrasound that provides crystal clear image quality, whole-patient scanning capabilities, and intuitive software – to veterinary practices in the United States.

Alleviant Medical, Inc. today announced the closing of a $75 million equity financing co-led by S3 Ventures and RiverVest Venture Partners.

Lyfebulb is pleased to announce the winners for the Innovation Challenge “Addressing Unmet Needs in IBD” in collaboration with Bristol Myers Squibb.

Ionis Pharmaceuticals, Inc. announced that Chief Scientific Officer C. Frank Bennett, Ph.D., has been named a co-recipient of the Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research.